Skip to content
AnalystLens

Rocket Lab 8-K Report, Financial Results (Nov 12, 2024)

Reports
Earnings & Results·Exhibits & Filings
Filing Date
Filed November 12, 2024
Period End
November 12, 2024
Security
RKLB
In the record · 2020–202610-K810-Q188-K88

RKLB filed 8 annual reports (10-K), 18 quarterly reports (10-Q) and 88 current reports (8-K) between 2020 and 2026.

  1. Restatement8-K · May ’21May ’21
  2. Leadership change8-K · Sep ’22Sep ’22
  3. Material agreement8-K · Jan ’24Jan ’24
  4. Material agreement8-K · Jun ’26Jun ’26

01—Abstract

Summary

Summary of the 8-K filed November 12, 2024. Cited figures are marked; the original filing is the authoritative source.

Rocket Lab USA (RKLB) reported third-quarter 2024 results on November 12, 2024 (furnished under Item 2.02 with press release Exhibit 99.1).

Revenue rose 55% year-over-year to $104.8 milliona, up from $67.7 million, and nine-month revenue reached $303.8 million. Gross profit was $28.0 million (26.7% GAAP gross margin), but the company remained unprofitable: GAAP operating loss widened to $51.9 million and net loss was $51.9 million, or $(0.10) per share. Adjusted EBITDA was a loss of $30.9 million, compared with a $15.5 million loss a year earlier.

Operating expenses rose sharply as R&D nearly doubled to $47.7 millionb, reflecting Neutron development and Archimedes engine testing. Balance sheet liquidity improved materially during the period. Cash and cash equivalents rose to $292.5 million, and total cash plus marketable securities (current and non-current) was roughly $504 million, versus about $324 million at year-end 2023.

The company issued $355 millionc of convertible senior notes and used part of the proceeds to repay the $48.9 million Trinity Loan and purchase capped calls. Total liabilities increased to $733 million, largely due to the convertible notes, and stockholders' equity fell to $420 million from $555 million as the accumulated deficit grew. Operating cash burn was $46.5 million over nine months, and capital expenditures were $45.5 million.

Management highlighted a record backlog of $1.05 billiond, 12 Electron launches year-to-date (a company record), $55 million in new Electron contracts, and a Neutron launch services agreement with a confidential constellation customer. Guidance for Q4 2024 calls for revenue of $125 million to $135 million, GAAP gross margin of 26% to 28%, and adjusted EBITDA loss of $27 million to $29 million. Investors should weigh strong top-line growth and backlog against a persistent operating loss, rising R&D spending, and dilution risk from the convertible notes.

02—Key points

Key Highlights

  1. Q3 2024 revenue of $104.8M grew 55% year-over-year from $67.7M, with nine-month revenue of $303.8M up from $184.6M.
  2. GAAP net loss widened to $51.9M ($0.10 per share) from $40.6M a year earlier; GAAP operating loss was $51.9M versus $38.9M.
  3. Adjusted EBITDA loss was $30.9M in Q3 2024, compared with a $15.5M loss in Q3 2023.
  4. Research and development expense, net, rose to $47.7M from $26.6M, driven by Neutron and Archimedes engine development.
  5. Backlog reached a record $1.05B, with $55M in new Electron contracts signed in Q3 at an average selling price of $8.4M.
  6. Issued $355M of convertible senior notes; cash and equivalents were $292.5M at quarter-end, and total cash plus marketable securities was roughly $504M.
  7. Q4 2024 guidance calls for revenue of $125M to $135M, a record quarter, with GAAP gross margin of 26% to 28% and adjusted EBITDA loss of $27M to $29M.

03—Questions

Frequently Asked Questions

  1. How did Rocket Lab perform financially in Q3 2024?

    Revenue grew 55% year-over-year to $104.8 million. However, the company posted a GAAP net loss of $51.9 million, or $(0.10) per share, and an adjusted EBITDA loss of $30.9 million, both wider than a year earlier as operating expenses increased.

  2. What is driving the increase in operating expenses?

    Research and development, net, nearly doubled to $47.7 million from $26.6 million. The increase reflects continued development of the Neutron medium-lift rocket and Archimedes engine testing, which doubled in cadence during the quarter.

  3. Is Rocket Lab's liquidity sufficient to fund its operations?

    Cash and marketable securities totaled roughly $504 million at September 30, 2024, after the $355 million convertible notes offering. Nine-month operating cash burn was $46.5 million and capital expenditures were $45.5 million, though the company continues to report losses and its free cash flow remains negative.

  4. What does the convertible note issuance mean for shareholders?

    The $355 million of convertible senior notes adds debt to the balance sheet and can dilute existing shareholders if converted into equity. Capped call purchases of $43.2 million were made to offset some of this dilution up to a specified price. Stockholders' equity declined to $420 million from $555 million.

  5. What should investors expect for Q4 2024?

    Management guides to record revenue of $125 million to $135 million, GAAP gross margins of 26% to 28%, GAAP operating expenses of $84 million to $86 million, and an adjusted EBITDA loss of $27 million to $29 million. Forward results depend on Electron launch execution and Neutron development progress.

04—Continue

← View all 8-K filings